Biotech Top Gainers, Halozyme Therapeutics, TESARO, Puma Biotechnology, Idenix Pharmaceuticals, AEterna Zentaris

Stocks of the DayShares of Halozyme Therapeutics, Inc (NASDAQ:HALO) advanced Thursday after the company posted data of clinical trials for an experimental cancer drug. Shares surged 1.24 US dollars, or 18.4 %, to close at 7.98 US dollars. In the past 52 weeks the range of the stock was in 3.86 to 9.92 US dollars.

Shares of biopharmaceutical company TESARO Inc (NASDAQ:TSRO) advanced nearly 17 % after the firm declared its final phase 1 data for Niraparib. It is intended to be used for the treatment of ovarian and breast cancer.

The President and CEO of Neuralstem, Inc (NYSE: CUR) is scheduled to present at the Annual World Stem Cells and Regenerative Medicine Congress on Thursday, May 23, in London. The presentation will define how cell therapies will be supportive for clinicians and integrated into hospital settings.

Puma Biotechnology Inc (NYSE:PBYI) disclosed first quarter financial results ended March 31, 2013. The comparisons are made for the first quarter of 2013 compared to the first quarter of 2012. Company’s net loss was 11.8 million US dollars, or 41 cents per share, for the first quarter of 2013. for the first quarter of 2012 the net loss was 11.9 million US dollars, or 59 cents a share.

Shares of Idenix Pharmaceuticals Inc (NASDAQ:IDIX) currently trades for 3.64 US dollars and has reduced 24.95 percent year to date.

AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) has recently went into an agreement with Merck Serono to gain manufacturing rights for Cetrotide. Company also intends to sign a partnership to develop Ergomed for endometrial cancer.

Let’s have an over overview of last session activity of biotech top gainers.

Halozyme Therapeutics, Inc. (NASDAQ:HALO) shares rose 18.40% in last trading session and is closed at $ 6.74 while trading in range of $ 7.25 – 8.06 with average volume 1.05 million shares. HALO price to sales ratio in past twelve months was calculated as 21.33 and price to cash ratio as 9.04. HALO return on equity ratio is recorded as -179.24% and its return on assets is -53.42%.

TESARO Inc (NASDAQ:TSRO) shares rose 14.09% in last trading session and is closed at $ 31.45 while trading in range of $ 32.07 – 36.80 with average volume 175,655.00 million shares. TSRO price to cash ratio in past twelve months was calculated as 5.88. TSRO return on equity ratio is recorded as -92.16% and its return on assets is -48.58%.

Neuralstem, Inc. (NYSEMKT:CUR) shares rose 11.54% in last trading session and is closed at $1.30 while trading in range of $1.28 – 1.50with average volume 420,813.00 million shares. CUR price to sales ratio in past twelve months was calculated as 243.32 and price to cash ratio as 13.41. CUR return on equity ratio is recorded as -234.50% and its return on assets is -157.70%.

Puma Biotechnology Inc (NYSE:PBYI) shares rose 8.52% in last trading session and is closed at $ 32.05 while trading in range of $ 31.73 – 34.78 with average 128,244.00 shares. PBYI price to cash ratio in past twelve months was calculated as 8.40. PBYI return on equity ratio is recorded as – 92.38% and its return on assets is -76.67%.

Idenix Pharmaceuticals Inc (NASDAQ:IDIX) shares rose 6.56% in last trading session and is closed at $ 3.66 while trading in range of $ 3.66 – 3.91 with average volume 758,661.00 shares. IDIX price to sales ratio in past twelve months was calculated as 14.98 and price to cash ratio as 2.54. IDIX return on equity ratio is recorded as -57.47% and its return on assets is -42.19%.

AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) shares rose 5.64% in last trading session and is closed at $ 1.95 while trading in range of $ 1.98 – 2.18 with average volume 420.00 shares. AEZS price to sales ratio in past twelve months was calculated as 1.55 and price to cash ratio as 1.32. AEZS return on assets is -28.54%.

Leave a Reply